Norofert Past Earnings Performance
Past criteria checks 0/6
Norofert's earnings have been declining at an average annual rate of -22.9%, while the Chemicals industry saw earnings growing at 7.3% annually. Revenues have been growing at an average rate of 1.3% per year.
Key information
-22.9%
Earnings growth rate
-25.4%
EPS growth rate
Chemicals Industry Growth | 39.7% |
Revenue growth rate | 1.3% |
Return on equity | -22.3% |
Net Margin | -11.6% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Norofert makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 45 | -5 | 6 | 0 |
31 Mar 24 | 42 | -6 | 7 | 0 |
31 Dec 23 | 44 | -4 | 7 | 0 |
30 Sep 23 | 53 | 4 | 6 | 0 |
30 Jun 23 | 65 | 8 | 5 | 0 |
31 Mar 23 | 71 | 10 | 5 | 0 |
31 Dec 22 | 73 | 11 | 5 | 0 |
30 Sep 22 | 76 | 10 | 6 | 0 |
30 Jun 22 | 64 | 8 | 5 | 0 |
31 Mar 22 | 64 | 10 | 5 | 0 |
31 Dec 21 | 53 | 7 | 5 | 0 |
30 Sep 21 | 38 | 3 | 4 | 0 |
30 Jun 21 | 31 | 5 | 4 | 0 |
31 Mar 21 | 23 | 1 | 4 | 0 |
31 Dec 20 | 25 | 4 | 4 | 0 |
30 Sep 20 | 30 | 9 | 4 | 0 |
30 Jun 20 | 27 | 8 | 4 | 0 |
31 Mar 20 | 21 | 6 | 3 | 0 |
31 Dec 19 | 15 | 5 | 2 | 0 |
31 Dec 18 | 10 | 4 | 1 | 0 |
Quality Earnings: NRF is currently unprofitable.
Growing Profit Margin: NRF is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NRF is unprofitable, and losses have increased over the past 5 years at a rate of 22.9% per year.
Accelerating Growth: Unable to compare NRF's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NRF is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-5.7%).
Return on Equity
High ROE: NRF has a negative Return on Equity (-22.34%), as it is currently unprofitable.